Pentwater Capital Management’s Centessa Pharmaceuticals CNTA Stock Holding History

Pentwater Capital Management’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-8,170,000	Closed	-$325M	–	99
2026 Q1	$325M	Buy	+8,170,000	New	+$209M	1.68%	16

Pentwater Capital Management's CNTA Position: Q2 2026 in Review

Pentwater Capital Management sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 8,170,000 shares — an estimated $325M sold.

Pentwater Capital Management first reported a position in CNTA in Q1 2026 and held it in 1 quarter. The position peaked at $325M in Q1 2026. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

Pentwater Capital Management reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Pentwater Capital Management sold 8,170,000 Centessa Pharmaceuticals shares in Q2 2026, an estimated $325M.
Pentwater Capital Management first reported a position in Centessa Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Pentwater Capital Management's Centessa Pharmaceuticals position peaked at $325M in Q1 2026.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on Pentwater Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.